GBA1 and Parkinson disease: Papagiannakis et al. (2018) also collected erythrocyte membranes and detected higher levels of α-Syn dimers and the dimer to monomer ratio in mutant carriers of the GBA gene (GBA-PD) and PD patients without known mutations (Papagiannakis et al., 2018).